Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASPEN: Afinitor vs Sutent in Metastatic Non-Clear Cell RCC
NCT01108445Phase 2Completed
- Sponsor
- Duke University
- Start
- Sep 2010
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of everolimus in renal cell carcinoma (RCC), sponsored by Duke University. Started Sep 2010; status: completed.
02
Drugs
everolimus
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT01108445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01108445.